|
| Press Releases |
|
 |
|
| Thursday, August 18, 2022 |
|
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU |
| Malaysian Genomics Resource Centre Berhad's (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a memorandum of understanding (MoU) with MAHSA Health Sdn Bhd to discuss the formation of a strategic partnership promoting practice-based education, research and knowledge exchange. more info >> |
|
| Wednesday, July 20, 2022 |
|
|
UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide |
| UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market: 0155) announced today that they have signed a collaborative agreement to integrate genomic testing services into digital health platform, iMedic(TM), elevating healthcare services to the next level. more info >> |
|
| Friday, July 15, 2022 |
|
|
Malaysian Genomics Appoints New Chairman |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors. more info >> |
|
| Wednesday, July 13, 2022 |
|
|
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. more info >> |
|
| Friday, July 8, 2022 |
|
|
Malaysian Genomics Proposes Private Placement |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is proposing to undertake a private placement of up to 10% of its total number of issued shares or up to 12.42 million new placement shares at an issue price to be determined for third-party investors that will be identified later. more info >> |
|
| Wednesday, July 6, 2022 |
|
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group's wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. more info >> |
|
| Thursday, June 23, 2022 |
|
|
Malaysian Genomics Resource Centre to Offer Pioneering Holistic Renal Care via New Venture |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is acquiring a 51% stake in Aquahealth Sdn Bhd, a kidney dialysis operator, from Rinani Renal Berhad. more info >> |
|
| Monday, June 13, 2022 |
|
|
Malaysian Genomics Resource Centre Berhad Gets Affected Issuer Status Uplifted |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that it is uplifted from being classified as an affected listed corporation effective 13 June 2022. more info >> |
|
| Monday, May 23, 2022 |
|
|
Malaysian Genomics Resource Centre Berhad Posts 212% Increase in Revenue for 3Q FY2022 |
| Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group registered a 211.66% increase in revenue to RM5.08 million for the third quarter ended 31 March 2022 (3Q 2022) compared with revenue of RM1.63 million for the same quarter of the previous financial year. more info >> |
|
| Thursday, April 28, 2022 |
|
|
Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara's Ramadhan Initiative |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to support Yayasan Seri Negara's (YSN) Ihya Ramadhan 2022 programme through a monetary donation to help those in need. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
LEXUS、モントレー・カー・ウィーク2022でNEXT CHAPTERモデルを出展
Aug 19, 2022 16:00: JST
|
|
|
台灣精品於 2022 年新加坡國際醫療展首次亮相 展出10 家醫療科技暨照護領域的創新企業
Aug 19, 2022 14:01 HKT/SGT
|
|
|
台灣精品於 2022 年新加坡國際醫療展首次亮相 展出10 家醫療科技暨照護領域的創新企業
Aug 19, 2022 14:01 HKT/SGT
|
|
|
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
Aug 19, 2022 14:00 HKT/SGT
|
|
|
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
Aug 19, 2022 14:00 HKT/SGT
|
|
|
港股稀缺标的百奥赛图今日开启招股
Aug 19, 2022 11:41 HKT/SGT
|
|
|
港股稀缺標的百奧賽圖今日開啟招股
Aug 19, 2022 11:40 HKT/SGT
|
|
|
Sirnaomics核心产品RNAi治疗药物STP705用于治疗面部原位鳞状细胞皮肤癌的I/II期临床试验完成首例受试者给药
Aug 19, 2022 11:32 HKT/SGT
|
|
|
Sirnaomics核心產品RNAi治療藥物STP705用於治療面部原位鱗狀細胞皮膚癌的I/II期臨床試驗完成首例受試者給藥
Aug 19, 2022 11:31 HKT/SGT
|
|
|
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ
Aug 19, 2022 11:30 HKT/SGT
|
|
|
顺丰同城H股全流通申请获中国证监会正式批准 业内：有利于改善流动性和成交量
Aug 19, 2022 10:32 HKT/SGT
|
|
|
順豐同城H股全流通申請獲中國證監會正式批准 業內：有利於改善流動性和成交量
Aug 19, 2022 10:31 HKT/SGT
|
|
|
After 500 per cent spike in a single day, MuskMelon NFT advances its game for yielding higher returns
Aug 19, 2022 09:00: JST
|
|
|
After 500 per cent spike in a single day, MuskMelon NFT advances its game for yielding higher returns
Aug 19, 2022 08:00 HKT/SGT
|
|
|
CTG DUTY-FREE HK Public Offering Has Been Fully Applied with High Multiple Order Coverage From International Placing
Aug 18, 2022 19:58 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
